Progressive decline in p23 expression one month after birth in mice and lower steady-state p23 levels in individuals with AD [14] prompted us to suggest that lower levels of p23 expression might be a critical factor that modulates the extent of Aβ production, and consequently contribute to disease pathogenesis. This evidence concerns the gene TMED10 and Alzheimer disease.